Literature DB >> 25019583

The role of microglia activation in the development of sepsis-induced long-term cognitive impairment.

Monique Michels1, Andriele S Vieira2, Francieli Vuolo1, Hugo Galvane Zapelini3, Bruna Mendonça4, Francielle Mina4, Diogo Dominguini4, Amanda Steckert5, Patrícia Fernanda Schuck3, João Quevedo6, Fabrícia Petronilho7, Felipe Dal-Pizzol8.   

Abstract

Oxidative stress and inflammation is likely to be a major step in the development of sepsis-associated encephalopathy (SAE) and long-term cognitive impairment. To date, it is not known whether brain inflammation and oxidative damage are a direct consequence of systemic inflammation or whether these events are driven by brain resident cells, such as microglia. Therefore, the aim of this study is to evaluate the effect of minocycline on behavioral and neuroinflammatory parameters in rats submitted to sepsis. Male Wistar rats were subjected to sepsis by cecal ligation and puncture (CLP). The animals were divided into sham-operated (Sham+control), sham-operated plus minocycline (sham+MIN), CLP (CLP+control) and CLP plus minocycline (CLP+MIN) (100 μg/kg, administered as a single intracerebroventricular (ICV) injection). Some animals were killed 24h after surgery to assess the breakdown of the blood brain barrier, cytokine levels, oxidative damage to lipids (TBARS) and proteins in the hippocampus. Some animals were allowed to recover for 10 days when step-down inhibitory avoidance and open-field tasks were performed. Treatment with minocycline prevented an increase in markers of oxidative damage and inflammation in the hippocampus after sepsis. This was associated with an improvement in long-term cognitive performance. In conclusion, we demonstrated that the inhibition of the microglia by an ICV injection of minocycline was able to decrease acute brain oxidative damage and inflammation as well as long-term cognitive impairment in sepsis survivors.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood brain-barrier; Encephalopathy; Microglia; Minocycline; Sepsis

Mesh:

Substances:

Year:  2014        PMID: 25019583     DOI: 10.1016/j.bbi.2014.07.002

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  54 in total

1.  Anthocyanins control neuroinflammation and consequent memory dysfunction in mice exposed to lipopolysaccharide.

Authors:  Fabiano B Carvalho; Jessié M Gutierres; Andressa Bueno; Paula Agostinho; Adriana M Zago; Juliano Vieira; Pâmela Frühauf; José L Cechella; Cristina Wayne Nogueira; Sara M Oliveira; Caroline Rizzi; Roselia M Spanevello; Marta M F Duarte; Thiago Duarte; Odir A Dellagostin; Cinthia M Andrade
Journal:  Mol Neurobiol       Date:  2016-05-11       Impact factor: 5.590

2.  P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction.

Authors:  Luiz Eduardo Baggio Savio; Mariana G Juste Andrade; Paola de Andrade Mello; Patrícia Teixeira Santana; Aline Cristina Abreu Moreira-Souza; Janaína Kolling; Aline Longoni; Linda Feldbrügge; Yan Wu; Angela T S Wyse; Simon C Robson; Robson Coutinho-Silva
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

3.  CD40-CD40 Ligand Pathway is a Major Component of Acute Neuroinflammation and Contributes to Long-term Cognitive Dysfunction after Sepsis.

Authors:  Monique Michels; Lucinéia Gainski Danieslki; Andriele Vieira; Drielly Florentino; Dhébora Dall'Igna; Letícia Galant; Beatriz Sonai; Francieli Vuolo; Franciele Mina; Bruna Pescador; Diogo Dominguini; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Fabrícia Petronilho
Journal:  Mol Med       Date:  2015-03-26       Impact factor: 6.354

4.  Microglial Activation Modulates Neuroendocrine Secretion During Experimental Sepsis.

Authors:  Luis Henrique Angenendt da Costa; Nilton Nascimento Santos-Junior; Carlos Henrique Rocha Catalão; Maria José Alves Rocha
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

Review 5.  Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis.

Authors:  Lucineia Gainski Danielski; Amanda Della Giustina; Marwa Badawy; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Fabrícia Petronilho
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

6.  Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.

Authors:  Juciano Gasparotto; Carolina S Girardi; Nauana Somensi; Camila T Ribeiro; José C F Moreira; Monique Michels; Beatriz Sonai; Mariane Rocha; Amanda V Steckert; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Daniel P Gelain
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

7.  Microglial Cells Depletion Increases Inflammation and Modifies Microglial Phenotypes in an Animal Model of Severe Sepsis.

Authors:  Monique Michels; Pricila Ávila; Bruna Pescador; Andriele Vieira; Mariane Abatti; Luana Cucker; Heloisa Borges; Amanda Indalécio Goulart; Celso Carvalho Junior; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol
Journal:  Mol Neurobiol       Date:  2019-04-24       Impact factor: 5.590

8.  Effect of (-)-α-Bisabolol on the Inflammatory Response in Systemic Infection Experimental Model in C57BL/6 Mice.

Authors:  Heitor Augusto Otaviano Cavalcante; Saulo Euclides Silva-Filho; Luiz Alexandre Marques Wiirzler; Gabriel Fernando Esteves Cardia; Nancy Sayuri Uchida; Francielli Maria de Souza Silva-Comar; Ciomar Aparecida Bersani-Amado; Roberto Kenji Nakamura Cuman
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

9.  Systemic Lipopolysaccharide Administration-Induced Cognitive Impairments are Reversed by Erythropoietin Treatment in Mice.

Authors:  Rong Gao; Yuan-hui Tang; Jian-hua Tong; Jian-Jun Yang; Mu-huo Ji; Si-hai Zhu
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

10.  S100A9 Upregulation Contributes to Learning and Memory Impairments by Promoting Microglia M1 Polarization in Sepsis Survivor Mice.

Authors:  Yan-Ling Liao; Xiao-Yan Zhou; Mu-Huo Ji; Liang-Cheng Qiu; Xiao-Hui Chen; Can-Sheng Gong; Ying Lin; Yan-Hua Guo; Jian-Jun Yang
Journal:  Inflammation       Date:  2020-09-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.